betamethasone dipropionate; calcipotriene · Mc2 · NDA 213422
Wynzora
Earliest generic entry, as listed
18 Mar 2039
Blocked by patent: US 11696919, US 12440499.
Listed patents · 3 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 11696919 | drug product · sets the listed date | 18 Mar 2039 |
| US 12440499 | drug product, use U-1408 · sets the listed date | 18 Mar 2039 |
| US 10265265 | drug product | 27 Sep 2027 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 213422 · 001 · RLD | cream, topical | 0.064%;0.005% | 18 Mar 2039 |